Alkermes FDA Refusal: Biotech ETFs Dragged Down
April 02, 2018 at 14:54 PM EDT
Biotechnology stocks and biotech ETFs were among the worst performing areas of the markets Monday as Alkermes (NasdaqGS: ALKS) shares plunged after the U.S. food and Drug Administration refused to review the drugmaker’s treatment for depression. The First Trust NYSE Arca Biotechnology Index...